Champion™ pET161 Gateway™ Expression Kit with Lumio™ Technology
Product Image
Invitrogen™

Champion™ pET161 Gateway™ Expression Kit with Lumio™ Technology

Um all Ihren Expressionsansprüche zu entsprechen, bietet Invitrogen modernste Gateway™-Zielvektoren für die Expression in E. coli-, Insekten-, Hefe- oder SäugetierzellenWeitere Informationen
Have Questions?
KatalognummerMenge
125830436μ g
Katalognummer 12583043
Preis (EUR)
1.316,00
Each
-
Zum Warenkorb hinzufügen
Menge:
6μ g
Recurring order eligible. Learn more »
Preis (EUR)
1.316,00
Each
Zum Warenkorb hinzufügen
Ask our AI about this Product
Um all Ihren Expressionsansprüche zu entsprechen, bietet Invitrogen modernste Gateway™-Zielvektoren für die Expression in E. coli-, Insekten-, Hefe- oder Säugetierzellen sowie für die Produktion von nativen Proteinen bzw. von Fusionsproteinen am N- bzw. C-Terminal. Alle Gateway™-Zielvektoren verfügen über attR-Stellen für die Rekombination mit jedem von attL-flankierten Fragment, unabhängig davon, ob es sich um einen Entry-Klon oder einen Ultimate™ RF-Klon handelt. In der folgenden Tabelle sind die zahlreichen verfügbaren Zielvektoren aufgeführt.

Zusätzliches Material erforderlich, separat erhältlich: Gateway™ Entry-Klon, Gateway™ LR Clonase™ Enzymgemisch und Reaktionspuffer.
Nur für Forschungszwecke. Nicht zur Verwendung bei diagnostischen Verfahren.
Specifications
Bakterielle AntibiotikaresistenzAmpicillin (AMPR)
Bakterien- oder HefenstammBL21 Star™(DE3), TOP10
Konstitutives oder induktives SystemInduzierbar
DetektionsstelleIn-Gel-Detektion
ExpressionsmechanismusZellbasierte Expression
ExpressionssystemE. coli
InduktionsmittelIPTG
ProdukttypExpressionskit
Menge6μ g
Selektionsmittel (eukaryotisch)Keine
VektorpET
KlonierungsmethodeGateway™
ProduktlinieChampion™, Gateway™, Lumio™
PromoterT7
ProteinmarkierungHis Tag (6x), Lumio
Unit SizeEach
Inhalt und Lagerung
Alle Zielvektoren werden lyophilisiert und superspiralisiert geliefert.
Have questions about this product? Ask our AI assisted search.
This is an AI-powered search and may not always get things right. You can help us make it better with a thumbs up or down on individual answers or by selecting the “Give feedback" button. Your search history and customer login information may be retained by Thermo Fisher and processed in accordance with our Privacy Notice.

Kunden, die diesen Artikel ansahen, interessierten sich auch für



Dokumente und Downloads

Zertifikate

0 Ergebnisse angezeigt, oben nach einem bestimmten Zertifikat suchen

Sicherheitsdatenblätter

Vektorinformationen

Vektorname
Vektorkarte
Polylinker
Sequenz
Einschränkung
pIND-E
pET161-GW/CAT

Häufig gestellte Fragen (FAQ)

Several precautions may be taken to prevent problems resulting from basal level expression of a toxic gene of interest. These methods all assume that the T7-based or Champion-based expression plasmid has been correctly designed and created.

- Propagate and maintain your expression plasmid in a strain that does not contain T7 RNA polymerase (i.e., DH5α).
- If using BL21 (DE3) cells, try growing cells at room temperature rather than 37 degrees C for 24-48 hr.
- Perform a fresh transformation using a tightly regulated E. coli strain, such as BL21-AI cells.
- After following the transformation protocol, plate the transformation reaction on LB plates containing 100 µg/mL ampicillin and 0.1% glucose. The presence of glucose represses basal expression of T7 RNA polymerase.
- Following transformation of BL21-AI cells, pick 3 or 4 transformants and inoculate directly into fresh LB medium containing 100 µg/mL ampicillin or 50 µg/mL carbenicillin (and 0.1% glucose, if desired). When the culture reaches an OD600 of 0.4, induce expression of the recombinant protein by adding L-arabinose to a final concentration of 0.2%.
- When performing expression experiments, supplement the growth medium with 0.1% glucose in addition to 0.2% arabinose.
- Try a regulated bacterial expression system such as our pBAD system.

Find additional tips, troubleshooting help, and resources within our Protein Expression Support Center.

Typically, if you see 1-2 dominant bands, translation stopped prematurely due to codon usage bias. With degradation, you usually see a ladder of bands. With degradation, you can try using a protease inhibitor and add it to the lysis buffer to help prevent degradation. If degradation is the issue, a time point experiment can be done to determine the best time to harvest the cells.

Find additional tips, troubleshooting help, and resources within our Protein Expression Support Center.

If you are having a solubility issue, try to decrease the temperature or decrease the amount of IPTG used for induction. You can also try a different, more stringent cell strain for expression. Adding 1% glucose to the bacterial culture medium during expression can also help.

Find additional tips, troubleshooting help, and resources within our Protein Expression Support Center.

- Inoculate from fresh bacterial cultures, since higher protein yields are generally obtained from a fresh bacterial colony.

- Check the codon usage in the recombinant protein sequence for infrequently used codons. Replacing the rare codons with more commonly used codons can significantly increase expression levels. For example, the arginine codons AGG and AGA are used infrequently by E. coli, so the level of tRNAs for these codons is low.

- Add protease inhibitors, such as PMSF, to buffers during protein purification. Use freshly made PMSF, since PMSF loses effectiveness within 30 min of dilution into an aqueous solution.

- If you are using ampicillin for selection in your expression experiments, you may be experiencing plasmid instability due to the absence of selective conditions. This occurs as the ampicillin is destroyed by β-lactamase or hydrolyzed under the acidic media conditions generated by bacterial metabolism. You may want to substitute carbenicillin for ampicillin in your transformation and expression experiments.

- The recombinant protein may be toxic to bacterial cells. Try a tighter regulation system for competent cell expression such as BL21-AI. You may also consider trying a different expression system such as the pBAD system.

Find additional tips, troubleshooting help, and resources within our Protein Expression Support Center.

This typically occurs when your gene of interest is toxic. Try using a tighter regulation system, such as BL21 (DE3) (pLysS) or BL21 (DE3) (pLysE), or BL21(AI).

Find additional tips, troubleshooting help, and resources within our Protein Expression Support Center.

Geben Sie die Katalognummer, den Namen oder Link frei.

1x1 image pixel for data collection